[Pe-070] English Poster Session 070「Clinical trials and Drug development」

[Pe-070-3] A phase 1 study of NS-035 in patients with Fukuyama congenital muscular dystrophy

Go Fujino¹, Asuka Kitamura¹, Akiko Takahashi¹, Meiko Maeda¹, Akatsuki Kubota¹, Yukino Tokuyama², Ikue Wada², Kazuhiro Kobayashi³, Hirofumi Komaki⁴, Mariko Taniguchi-Ikeda⁵, Keiko Ishigaki⁶, Tatsushi Toda¹ (1.Department of Neurology, Graduate School of Medicine, The University of Tokyo, Japan, 2.Clinical Research Promotion Center, The University of Tokyo Hospital, Japan, 3.Division of Molecular Brain Science, Kobe University Graduate School of Medicine, Japan, 4.Department of Child Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Japan, 5.Department of Clinical Genetics, Fujita Health University Hospital, Japan, 6.Department of Pediatrics, Tokyo Women's Medical University School of Medicine, Japan)